Report on recent insight into molecular genetic alterations and target therapy in T-cell acute lymphoblastic leukemia in the 54th ASH annual meeting

VernacularTitle:T细胞-急性淋巴细胞白血病分子遗传学改变和靶向治疗新进展:第54届美国血液学会年会报道
Author: Yangqiu LI ; Huo TAN
Publication Type:Journal Article
Keywords: T-cell acute lymphoblastic leukemia; Gene mutation/delection; Gene overexpression; Target therapy; Prognosis; ASH annual meeting
From: Journal of Leukemia & Lymphoma 2013;22(1):1-3,7
CountryChina
Language:Chinese
Abstract: T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive hematologic malignancy associated with poor prognosis.Increasing data regarding to alteration of gene expression signatures of oncogenes and tumor suppressors involved in the pathogenesis of T-ALL and the major mechanisms of T-cell transformation may contribute to define the biological markers for treatment response and prognosis,and has important clinical implications.In this review,advance knowledge concerning the characteristics of early T-cell precursor ALL,the alteration of TAL1 and NOTCH1 related genes and target inhibiton effects based on these alterations from 2012 the 54th ASH annual meeting ars summarized.